首页> 外文OA文献 >CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn’s Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide

【2h】

CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn’s Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide

机译：CCL20受肠上皮细胞中的TGF-β1负调节，并且在Crohn病患者中减少了对蒙古森的成功反应，Smad7反义寡核苷酸

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Irene Marafini; Ivan Monteleone; Vincenzo Dinallo; Davide Di Fusco; Veronica De Simone; Federica Laudisi; Massimo Claudio Fantini; Antonio Di Sabatino; Francesco Pallone; Giovanni Monteleone;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CCL20 Is Negatively Regulated by TGF-beta 1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide [J] . Marafini Irene, Monteleone Ivan, Dinallo Vincenzo, Journal of Crohn’s & colitis . 2017,第5期

机译：CCL20受肠上皮细胞中TGF-β1负调节，并减少克罗恩病患者，患有蒙古森的成功反应，Smad7反义寡核苷酸
2. Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease [J] . Monteleone G., Di Sabatino A., Ardizzone S., Alimentary pharmacology & therapeutics. . 2016,第6期

机译：患者特征对口服Smad7反义寡核苷酸蒙格森（GED-0301）在活动性克罗恩病中的临床疗效的影响
3. Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease [J] . Ardizzone Sandro, Bevivino Gerolamo, Monteleone Giovanni Therapeutic advances in gastroenterology. . 2016,第4期

机译：患有活动性克罗恩病的患者，口服Smad7反义寡核苷酸Mongersen
4. Cellular immune response and gene expression profiling in Crohn's disease patients associated with Mycobacterium avium subspecies paratuberculosis [D] . Romero, Claudia M. 2004

机译：鸟分枝杆菌副结核分枝杆菌相关克罗恩病患者的细胞免疫应答和基因表达谱
5. Mongersen an oral Smad7 antisense oligonucleotide in patients with active Crohn’s disease [O] . Sandro Ardizzone, Gerolamo Bevivino, Giovanni Monteleone 2016

机译：口服Smad7反义寡核苷酸Mongersen用于患有活动性克罗恩病的患者
6. Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease [O] . Ardizzone, S, Bevivino, G, Monteleone, G 2016

机译：患有活动性克罗恩病的患者，口服Smad7反义寡核苷酸Mongersen

CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn’s Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide

著录项

相似文献

相关主题

期刊订阅